Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Injection crawled date : 2021 - 09 - 01 save search
Revance Announces Publication of Results on Static Glabellar Lines With Repeated Treatment of DaxibotulinumtoxinA for Injection From the SAKURA Clinical Program in Dermatologic Surgery
Published: 2021-09-01 (Crawled : 13:15) - biospace.com/
RVNC | $3.66 0.55% 0.68% 1.4M
|
Health Technology
|
| O: -0.15%
H: 1.57%
C: 1.31%
treatment injection results
Merck and Ridgeback Biotherapeutics Announce Initiation of Pivotal Phase 3 MOVe-AHEAD Study Evaluating Molnupiravir for Post-Exposure Prophylaxis of COVID-19 Infection
Published: 2021-09-01 (Crawled : 12:00) - biospace.com/
MRK | $126.88 -0.05% 0.43% 4.7M
|
Health Technology
|
| O: -0.09%
H: 0.76%
C: -0.05%
covid phase 3 iot molnupiravir injection infections
U.S. Government Exercises Option to Purchase Additional RAPIVAB® (peramivir injection) from BioCryst for Delivery to Strategic National Stockpile
Published: 2021-09-01 (Crawled : 11:00) - globenewswire.com
BCRX | News | $4.38 -0.68% -0.8% 3.6M
|
Health Technology
|
| O: -0.19%
H: 1.95%
C: 1.64%
injection liver
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.